Hyperice, Inc., commonly known as Hyperice, is an American health technology company headquartered in Irvine, California. Founded in 2010 by Anthony Katz, it is a privately held, venture capital-backed company. The company was valued at $700 million as of October 2020 and employs between 100 and 175 individuals.
Hyperice specializes in designing and manufacturing products for recovery and movement enhancement. Its product lines leverage vibration, percussion, dynamic air compression, and thermal technologies. Key offerings include percussion massage devices (e.g., Hypervolt line), dynamic air compression systems (e.g., Normatec, acquired in 2020), heat and vibration massage products (Venom line), contrast therapy devices (Hyperice X), and vibrating rollers (Vyper and Hypersphere). These products are used by professional athletes, sports leagues, and active individuals globally. In 2025, Hyperice also launched Hyperboot Nike x Hyperice compression boots in collaboration with Nike.
In terms of patent litigation, Hyperice, Inc. primarily appears as a defendant. The company has been named as a defendant in one tracked case and has no recorded appearances as a plaintiff. This posture indicates that Hyperice is an operating company defending against patent infringement allegations, rather than a non-practicing entity (NPE) asserting patents.
The sole tracked case involving Hyperice is Sichuan Qianli-Beoka Medical Technology Inc. et al. v. Hyperice, Inc. et al. (filed 2024-06-25), which is pending in the U.S. District Court for the Central District of California. The company has expanded its technology portfolio through strategic acquisitions, including Normatec in 2020 and Recoverx in 2021.